EUVIMEDEUVIMED entdecken
Crossref

Palmitic acid causes hepatocyte inflammation by suppressing the BMAL1-NAD+-SIRT2 axis

Savera Aggarwal, Archana Rastogi, Rakhi Maiwall, Jayesh K Sevak, Vipin Yadav, Jaswinder Maras, Sherin Sarah Thomas, Pratibha R Kale, Viniyendra Pamecha, Nagarajan Perumal, Nirupama Trehanpati, Gayatri Ramakrishna

Journal of Physiology and Biochemistry · 2024

DOI: 10.1007/s13105-024-01042-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Physiology and Biochemistry, 2024. Verfasst von Savera Aggarwal und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, Delhi, India. Hauptthemen laut MEDLINE: Palmitic Acid, Sirtuin 2, Hepatocytes, NAD. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Palmitic acid is the most abundant saturated fatty acid in circulation and causes hepatocyte toxicity and inflammation. As saturated fatty acid can also disrupt the circadian rhythm, the present work evaluated the connection between clock genes and NAD+ dependent Sirtuins in protecting hepatocytes from lipid-induced damage. Hepatocytes (immortal cells PH5CH8, hepatoma cells HepG2) treated with higher doses of palmitic acid (400-600μM) showed typical features of steatosis accompanied with growth inhibition and increased level of inflammatory markers (IL-6 IL-8, IL-1α and IL-1β) together with decline in NAD+ levels. Palmitic acid treated hepatocytes showed significant decline in not only the protein levels of SIRT2 but also its activity as revealed by the acetylation status of its downstream targets (Tubulin and NF-ƙB). Additionally, the circadian expression of both SIRT2 and BMAL1 was inhibited in presence of palmitic acid in only the non-cancerous hepatocytes, PH5CH8 cells. Clinical specimens obtained from subjects with NASH-associated fibrosis, ranging from absent (F0) to cirrhosis (F4), showed a significant decline in levels of SIRT2 and BMAL1, especially in the cirrhotic liver. Ectopic expression of BMAL1 or activating SIRT2 by supplementation with nicotinamide riboside (precursor of NAD+) dampened the palmitic acid induced lipoinflammation and lipotoxicity more effectively in PH5CH8 cells as compared to HepG2 cells. Mechanistically, palmitic acid caused transcriptional suppression of SIRT2 by disrupting the chromatin occupancy of BMAL1 at its promoter site. Overall, the work suggested that SIRT2 is a clock-controlled gene that is transcriptionally regulated by BMAL1. In conclusion the activation of the BMAL1-NAD+-SIRT2 axis shows hepatoprotective effects by preventing lipotoxicity and dampening inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Palmitic AcidSirtuin 2HepatocytesNADARNTL Transcription FactorsHumansHep G2 CellsNon-alcoholic Fatty Liver DiseaseMaleNiacinamidePyridinium CompoundsInflammationLiver CirrhosisCircadian RhythmSignal Transduction

Stichwörter der Autor:innen

BMAL1Circadian rhythmLipoinflammationNAD+NAFLDPalmitic acidSIRT2

Substanzen

Palmitic AcidSirtuin 2NADSIRT2 protein, humanARNTL Transcription FactorsBMAL1 protein, humanNiacinamidePyridinium Compoundsnicotinamide-beta-riboside

Autor:innen und Institutionen

  • Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, Delhi, India.
  • Departmentt of Pathology, Institute of Liver and Biliary Sciences, Delhi, India.
  • Department of Hepatology, Institute of Liver and Biliary Sciences, Delhi, India.
  • Department of Biochemistry, Institute of Liver and Biliary Sciences, Delhi, India.
  • Department of Microbiology, Institute of Liver and Biliary Sciences, Delhi, India.
  • Department of Hepato-Pancreato-Biliary Surgery, Institute of Liver and Biliary Sciences, Delhi, India.

Zitieren

APA

Aggarwal, S., Rastogi, A., Maiwall, R., Sevak, J. K., Yadav, V., Maras, J., Thomas, S. S., Kale, P. R., Pamecha, V., Perumal, N., Trehanpati, N., & Ramakrishna, G. (2024). Palmitic acid causes hepatocyte inflammation by suppressing the BMAL1-NAD+-SIRT2 axis. Journal of Physiology and Biochemistry. https://doi.org/10.1007/s13105-024-01042-x

Vancouver

Aggarwal S, Rastogi A, Maiwall R, Sevak JK, Yadav V, Maras J, et al. Palmitic acid causes hepatocyte inflammation by suppressing the BMAL1-NAD+-SIRT2 axis. Journal of Physiology and Biochemistry. 2024. doi:10.1007/s13105-024-01042-x

BibTeX
@article{Aggarwal2024,
  author = {Aggarwal, Savera and Rastogi, Archana and Maiwall, Rakhi and Sevak, Jayesh K and Yadav, Vipin and Maras, Jaswinder and Thomas, Sherin Sarah and Kale, Pratibha R and Pamecha, Viniyendra and Perumal, Nagarajan and Trehanpati, Nirupama and Ramakrishna, Gayatri},
  title = {Palmitic acid causes hepatocyte inflammation by suppressing the BMAL1-NAD+-SIRT2 axis},
  journal = {Journal of Physiology and Biochemistry},
  year = {2024},
  doi = {10.1007/s13105-024-01042-x}
}
Kostenlos starten →